Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Inj Trastuzumab Emtansene Tdm 160mg,Inj Trastuzumab 440mg,Cerviprime Gel,Ceritinib 150 Mg,Nicotene
|
| Description |
|
| Organisation | Department of Health and Family Welfare | Ministry of Health and Family Welfare |
| Tender Id | GEM/2023/B/3945214 |
|
Reference Number |
- |
| Tender Fee | - |
| EMD | - |
| Tender Value | - |
| Place | |
| Link |
View Original Tender Notice
https://gem.gov.in/ |
| Start Date | September 12, 2023 17:29 |
| End Date |
Expired
22/09/2023
Expired 1065 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Award of Contract & Bid Results
Awarded Contractor / Winner
KASHMIR PHARMA & SURGICALS
Contract Value
243360
Tender Status:
active
Additional Information:
Average Turn Over of Last 3 Years: 5 Lakhs
Experience with Gov. Required: Years
Buyer Name:
Mohammad Ayoub Beigh
Ministry:
Ministry Of Health And Family Welfare
Department:
Department Of Health And Family Welfare
Organisation:
Directorate Of Health Services Kashmir
Technical Evaluation Results
| S.No. | Seller Name | Offered Item | Participated On | MSE/MII Status | Status |
|---|---|---|---|---|---|
| 1 | HILAL-E-AHMAR ENTERPRISES | - | 21-09-2023 22:01:08 | MII MSE | Qualified |
| 2 | KASHMIR PHARMA & SURGICALS | - | 25-09-2023 15:58:18 | MII MSE | Qualified |
| 3 | syncure pharmaceuticals | - | 30-09-2023 08:57:52 | MII MSE | Qualified |
Financial Evaluation Results
| S.No. | Seller Name | Offered Item | Total Price | Rank |
|---|---|---|---|---|
| 1 | KASHMIR PHARMA & SURGICALS(MSE,MII)( MSE Social Category:General ) | Item Categories : Inj Trastuzumab Emtansene TDM 160mg,Inj Trastuzumab 440mg,Cerviprime Gel,Ceritinib 150 mg,Nicotene | 243360.00 | L1 |
| 2 | HILAL-E-AHMAR ENTERPRISES (MSE,MII)( MSE Social Category:General ) | Item Categories : Inj Trastuzumab Emtansene TDM 160mg,Inj Trastuzumab 440mg,Cerviprime Gel,Ceritinib 150 mg,Nicotene | 289404.00 | L2 |
| 3 | syncure pharmaceuticals (MSE,MII)( MSE Social Category:General ) | Item Categories : Inj Trastuzumab Emtansene TDM 160mg,Inj Trastuzumab 440mg,Cerviprime Gel,Ceritinib 150 mg,Nicotene | 339244.00 | L3 |
Ordered Items & Contract Pricing
| Product | Brand | Model | Ordered Quantity | Price |
|---|---|---|---|---|
| Inj Trastuzumab Emtansene TDM 160mg | NA | BOQ Item | 2 | ₹ 95000.000 |
| Inj Trastuzumab 440mg | NA | BOQ Item | 2 | ₹ 22400.000 |
| Cerviprime Gel | NA | BOQ Item | 150 | ₹ 28560.000 |
| Ceritinib 150 mg | NA | BOQ Item | 180 | ₹ 91800.000 |
| Nicotene 4 mg | NA | BOQ Item | 500 | ₹ 5600.000 |
Similar Tenders
Click
Here to Download Dockets
of your Industry type
of your Industry type